ArticleClinical and experimental nephrology2021

MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Ningmin Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.